Dexcom (DXCM) Change in Cash (2010 - 2026)

Dexcom (DXCM) has reported Change in Cash for 17 consecutive years, with -$13.2 million the latest figure, recorded in Q2 2026.

• On a quarterly basis, Change in Cash fell 105.19% year-over-year to -$13.2 million in Q2 2026; TTM through Jun 2026 was -$55.1 million, a 125.07% decrease from a year earlier, with the FY2025 full-year figure at $311.8 million, up 683.42% from the prior year.
• Change in Cash was -$13.2 million for Q2 2026 at Dexcom, down from $199.3 million in the prior quarter.
• Over five years, Change in Cash peaked at $676.6 million in Q3 2025 and troughed at -$917.8 million in Q4 2025.
• A 5-year average of $2.9 million and a median of -$14.2 million in 2024 frame the typical range for Change in Cash.
• Across the five-year window, Change in Cash soared 2862.18% in 2023 and sank 5978.15% in 2025, its largest moves.
• Over 5 years, Change in Cash stood at -$55.8 million in 2022, then tumbled by 38.53% to -$77.3 million in 2023, then soared by 80.47% to -$15.1 million in 2024, then slumped by 5978.15% to -$917.8 million in 2025, then surged by 98.56% to -$13.2 million in 2026.
• The last three Change in Cash figures came in at -$13.2 million (Q2 2026), $199.3 million (Q1 2026), and -$917.8 million (Q4 2025), per Business Quant data.